ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,036,000 | +70.5% | 87,108 | -10.3% | 0.02% | +71.4% |
| Q1 2019 | $2,367,000 | +76.8% | 97,096 | +3.3% | 0.01% | +55.6% |
| Q4 2018 | $1,339,000 | -21.1% | 93,953 | -15.8% | 0.01% | -25.0% |
| Q3 2018 | $1,697,000 | -12.3% | 111,624 | -3.3% | 0.01% | -7.7% |
| Q2 2018 | $1,936,000 | -2.3% | 115,378 | -5.0% | 0.01% | 0.0% |
| Q1 2018 | $1,982,000 | +14.1% | 121,448 | -10.5% | 0.01% | +8.3% |
| Q4 2017 | $1,737,000 | +30.2% | 135,701 | +25.2% | 0.01% | 0.0% |
| Q3 2017 | $1,334,000 | +54.9% | 108,423 | +5.3% | 0.01% | +33.3% |
| Q2 2017 | $861,000 | -12.1% | 102,920 | -6.0% | 0.01% | -10.0% |
| Q1 2017 | $979,000 | -19.4% | 109,467 | -20.8% | 0.01% | -23.1% |
| Q4 2016 | $1,215,000 | +70.4% | 138,231 | +30.8% | 0.01% | +30.0% |
| Q3 2016 | $713,000 | +60.9% | 105,649 | -15.1% | 0.01% | +66.7% |
| Q2 2016 | $443,000 | +21.7% | 124,443 | +0.9% | 0.01% | +20.0% |
| Q1 2016 | $364,000 | -36.3% | 123,363 | -8.8% | 0.01% | -28.6% |
| Q4 2015 | $571,000 | +2.7% | 135,228 | +10.9% | 0.01% | -12.5% |
| Q3 2015 | $556,000 | -40.9% | 121,891 | -6.6% | 0.01% | -38.5% |
| Q2 2015 | $941,000 | -8.5% | 130,511 | -6.5% | 0.01% | +8.3% |
| Q1 2015 | $1,028,000 | +90.0% | 139,543 | +22.0% | 0.01% | +100.0% |
| Q4 2014 | $541,000 | +28.5% | 114,344 | -3.0% | 0.01% | 0.0% |
| Q3 2014 | $421,000 | -33.0% | 117,855 | -14.4% | 0.01% | -25.0% |
| Q2 2014 | $628,000 | -39.6% | 137,737 | -37.7% | 0.01% | -38.5% |
| Q1 2014 | $1,040,000 | +227.0% | 221,262 | +248.4% | 0.01% | +160.0% |
| Q4 2013 | $318,000 | -55.5% | 63,499 | -44.7% | 0.01% | -70.6% |
| Q3 2013 | $714,000 | +60.8% | 114,866 | +17.4% | 0.02% | +88.9% |
| Q2 2013 | $444,000 | – | 97,856 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,850,650 | $75,330,000 | 5.64% |
| BVF INC/IL | 6,682,711 | $28,201,000 | 4.81% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,729,361 | $36,838,000 | 1.49% |
| First Light Asset Management, LLC | 530,391 | $2,238,000 | 0.94% |
| KOPP INVESTMENT ADVISORS LLC | 376,477 | $1,589,000 | 0.78% |
| Sarissa Capital Management LP | 700,000 | $2,954,000 | 0.57% |
| Orbimed Advisors | 10,689,000 | $45,108,000 | 0.41% |
| Bedell Frazier Investment Counselling, LLC | 178,971 | $755,000 | 0.37% |
| PINNACLE ASSOCIATES LTD | 3,453,487 | $14,574,000 | 0.31% |
| Artal Group S.A. | 3,710,000 | $15,656,000 | 0.29% |